Experienced and entrepreneurial executive with extensive pharmaceutical, biotechnology, and health-sector knowledge. Advocate for innovation and Technology Transfer, Rocio is currently CEO of Amadix, an innovative biotechnology company to develop cutting-edge diagnostic tools for cancer. Ms. Arroyo has more than 15 years of experience in the Pharmaceutical and Biotechnology industry. She filled the position of General Manager in Bionostra Biotechnology Applications in the Oncology area. She has been holding a range of positions in Eli Lilly, in a variety of therapeutic areas from oncology and gynecology to urology and endocrinology. Her expertise covers the full scope of the business starting as a researcher in Pharmacology, moving to the sales and marketing operations to business development, fundraising and P&L optimization. With a strategic vision oriented to maximize profitability in biotechnology / pharmaceutical companies, Rocio holds a BSc in Pharmacy from the Complutense University (Madrid, Spain) where she also completed graduate courses in Pharmacology, and a MBA from the IE Business School (Madrid, Spain). She is a Board Member of different Business Schools and Universities, and participate in different programs of mentoring for entrepreneurs.